OBI Pharma Inc 2022 Annual Report with Sustainability Disclosures
Company: OBI Pharma Inc
Sector: Manufacturing
Country: Taiwan
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 327
The report describes a 2022 year marked by continued new-drug research and development, with consolidated net revenue of NT$4,711 thousand and 260 employees including subsidiaries. The company established a Sustainability Development Execution Committee under Board of Directors oversight and describes its sustainability reporting as aligned with GRI Standards 2021, SASB criteria, and TCFD. Environmental disclosures report 9.25 tons of waste and an 11.94% reduction in annual electricity consumption compared with 2021, while no external assurance had yet been executed.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.